Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.

“I find MedCity News a great resource for taking the pulse of the market and sourcing potential investment opportunities.”

Bernie Rudnick, Angel investor and advisor, CapGenic Advisors, LLC

Sign up for our daily newsletter

These two takes on Obamacare really got readers worked up this week

8:00 am by | 0 Comments

It’s not uncommon for political-related posts to garner lots of story comments and social media posts, but MedCity News reader linked and tweeted one post in record numbers this week.

Drs. Kevin Smith and Richard Amerling ruffled some – ok, lots – of feathers with their posts on the “right” to healthcare and how to survive Obamacare. We highlighted one reader’s insightful response to Smith in a follow-up post.

Also this week…

Mobile health company Ginger.io, which builds apps for behavioral health, raised $6.5 million in a round led by Khosla Ventures.

Boston Scientific and Medtronic are poised to gain market share in 2013 if St. Jude Medical pulls its Durata off the market, which at least one analyst says is quite likely.

Which social media platform should you be on? This infographic will point you in the right direction.

Avaxia Biologics received clearance from the FDA to begin clinical trials of its oral drug for inflammatory bowel disease.

Tweets we liked this week.

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Deanna Pogorelc

By Deanna Pogorelc MedCity News

Deanna Pogorelc is a Cleveland-based reporter who writes obsessively about life science startups across the country, looking to technology transfer offices, startup incubators and investment funds to see what’s next in healthcare. She has a bachelor’s degree in journalism from Ball State University and previously covered business and education for a northeast Indiana newspaper.
More posts by Author